Clinical Trial Update: Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of temsirolimus in men with castration-resistant metastatic prostate cancer evaluating circulating tumor cell biology; the study was terminated an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-01-10